Covestor LTD Emergent Bio Solutions Inc. Transaction History

Covestor LTD

$181 Million
Q3 2025

A detailed history of Covestor LTD transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Covestor LTD holds 4,011 shares of EBS stock, worth $40,551. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,011

Previous 4,028 0.42%

Holding current value

$40,551

Previous $26,000 34.62%

% of portfolio

0.02%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	SELL	$5.63 - $9.32 $95 - $158	-17 Reduced 0.42%	4,011 $35,000
Q2 2025 Aug 11, 2025	BUY	$4.26 - $6.94 $596 - $971	140 Added 3.6%	4,028 $26,000
Q1 2025 May 12, 2025	BUY	$4.66 - $11.66 $4,389 - $10,983	942 Added 31.98%	3,888 $19,000
Q4 2024 Feb 13, 2025	BUY	$7.72 - $11.97 $22,333 - $34,629	2,893 Added 5458.49%	2,946 $28,000
Q3 2024 Nov 01, 2024	SELL	$5.72 - $14.77 $143 - $369	-25 Reduced 32.05%	53 $0

Q2 2024 Aug 09, 2024	BUY	$1.86 - $6.98 $96 - $362	52 Added 200.0%	78 $0
Q1 2024 May 10, 2024	SELL	$1.5 - $3.41 $1 - $3	-1 Reduced 3.7%	26 $0
Q4 2023 Feb 09, 2024	BUY	$1.82 - $3.16 $25 - $44	14 Added 107.69%	27 $0
Q3 2023 Nov 13, 2023	BUY	$3.17 - $7.91 $25 - $63	8 Added 160.0%	13 $0
Q2 2023 Aug 11, 2023	SELL	$7.35 - $13.21 $7 - $13	-1 Reduced 16.67%	5 $0
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $36,945 - $65,836	-1,839 Reduced 99.67%	6 $0
Q2 2022 Aug 10, 2022	BUY	$27.42 - $43.63 $6,388 - $10,165	233 Added 14.45%	1,845 $57,000
Q1 2022 May 13, 2022	BUY	$36.48 - $52.22 $17,911 - $25,640	491 Added 43.8%	1,612 $66,000
Q4 2021 Feb 10, 2022	BUY	$33.11 - $55.01 $37,116 - $61,666	1,121 New	1,121 $49,000

Others Institutions Holding EBS

# of Institutions

191

Shares Held

41.3M

Call Options Held

899K

Put Options Held

256K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $504M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account